Water-Free Cyclosporine 0.1% in Dry Eye Disease: Formulation Rationale, Clinical Evidence, and Unresolved Questions
Drug Design, Development and Therapy · 2026-08 · Volume 20 · 1-9
DOI: 10.2147/dddt.s620553 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-08. Verfasst von Eleftherios Chatzimichail und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Cyclosporine, Dry Eye Syndromes, Immunosuppressive Agents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, University Hospital of Basel, Basel, Switzerland.
- Corneoplastic Unit, Queen Victoria Hospital, East Grinstead, UK.
- Research Institute of Ophthalmology, Giza, Egypt.
- Maidstone and Tunbridge Wells Hospital NHS Trust, Kent, UK.
- Vantage Biosciences, London, UK.
- First Department of Ophthalmology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
ORCID-Profile: Georgios D Panos
Zitieren
APA
Chatzimichail, E., Elalfy, M., Empeslidis, T., Panos, G. D., & Gatzioufas, Z. (2026). Water-Free Cyclosporine 0.1% in Dry Eye Disease: Formulation Rationale, Clinical Evidence, and Unresolved Questions. Drug Design, Development and Therapy, Volume 20, 1-9. https://doi.org/10.2147/dddt.s620553
Vancouver
Chatzimichail E, Elalfy M, Empeslidis T, Panos GD, Gatzioufas Z. Water-Free Cyclosporine 0.1% in Dry Eye Disease: Formulation Rationale, Clinical Evidence, and Unresolved Questions. Drug Design, Development and Therapy. 2026;Volume 20:1-9. doi:10.2147/dddt.s620553
BibTeX
@article{Chatzimichail2026,
author = {Chatzimichail, Eleftherios and Elalfy, Mohamed and Empeslidis, Theo and Panos, Georgios D and Gatzioufas, Zisis},
title = {Water-Free Cyclosporine 0.1% in Dry Eye Disease: Formulation Rationale, Clinical Evidence, and Unresolved Questions},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--9},
doi = {10.2147/dddt.s620553}
}
EUVIMED